17,261 trials
Pleomorphic Adenoma of the Parotid · Warthin Tumor · Head and Neck Disorder
Primary: Facial Nerve Correlation of Fluorescein Sodium With Electrostimulation — 3.8 score on a scale
Aging · Cognitive Function Abnormal · Cognitive Performance
Primary: Self-Perceived Need for Cognitive Training — 7.49; 3.34 score on a scale
Chronic Inducible Urticaria
Primary: Safety and Tolerability — 3; 7 Participants with a TEAE
Cicatricial Alopecia
Primary: Number of Participants With Treatment-Emergent Adverse Events — 0; 3 Participants
Chronic Kidney Disease Stage 3 · Chronic Kidney Disease Stage 4
Primary: Change in Plasma 8 Isoprostane From Baseline — 19.2; 35.0; 18.1; 56.3 pg/mL
Moderate to Severe Plaque Psoriasis
Primary: Plasma Concentration of Bimekizumab at Week 0 — NA; NA microgram per milliliter (µg/mL)
Cocaine-Related Disorders
Primary: Percentage of Abstinent Days — 97.43; 71.63; 98.11; 61.85 Percentage of abstinent days
Sjögren Syndrome
Primary: Cohort 1: Change in EULAR Sjögren Syndrome Disease Activity Index (ESSDAI) Score From Baseline at 24 Weeks as Compared to Placebo — -4.0; -7.0; -5.4; -6.9 Unit on a…
Non Small Cell Lung Cancer
Primary: Progression Free Survival at 15 Weeks. — 17; 18 Participants
Castration-Resistant Prostate Carcinoma · Stage IVB Prostate Cancer AJCC v8
Primary: Overall Response Rate (ORR) — 50 percentage of participants
Malignant Solid Neoplasm · Metastatic Lung Non-Small Cell Carcinoma · Stage IV Lung Non-Small Cell Cancer AJCC v7
Primary: Overall Response Rate (ORR) — 38; 33; 10; 17 ORR Percentage of participants whose tum
Prostate Cancer · Recurrent Prostate Cancer
Primary: Percentage of Participants With PSA50 Response — 2 Participants
COPD · Emphysema · Emphysema or COPD
Primary: Pulmonary Microvascular Blood Volume, CV — 0.89; 0.88; 0.92; 0.91 CV — p=0.84
Cytomegalovirus Infections · HIV Infections · Vaccine
Primary: Occurrence of Grade ≥3 AEs — 14; 5 Participants — p=0.79
Acute Coronary Syndrome · Lipid Disorder · Coronary Artery Disease
Primary: Low Density Lipoprotein - Cholesterol — -6.74; 0.53 mg/dL — p=0.27